» Articles » PMID: 20739503

Development of Human-murine Chimeric Immunoglobulin G for Use in the Serological Detection of Human Flavivirus and Alphavirus Antibodies

Overview
Date 2010 Aug 27
PMID 20739503
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Diagnosis of human arboviral infections relies heavily on serological techniques such as the immunoglobulin M (IgM) antibody capture enzyme-linked immunosorbent assay (MAC-ELISA) and the indirect IgG ELISA. Broad application of these assays is hindered by the lack of standardized positive human control sera that react with a wide variety of flaviviruses (e.g., dengue, West Nile, yellow fever, Japanese encephalitis, Saint Louis encephalitis, and Powassan viruses), or alphaviruses (e.g., Eastern equine encephalitis, Western equine encephalitis, Venezuelan equine encephalitis, and chikungunya viruses) that can cause human disease. We have created human-murine chimeric monoclonal antibodies (cMAbs) by combining the variable regions of flavivirus (6B6C-1) or alphavirus (1A4B-6) broadly cross-reactive murine MAbs (mMAbs) with the constant region of human IgG1. These cMAbs may be used as standardized reagents capable of replacing human infection-immune-positive control sera in indirect IgG ELISA for diagnosis of all human flaviviral or alphaviral infections. The IgG cMAbs secreted from plasmid-transformed Sp2/0-Ag14 cells had serological activity identical to that of the parent mMAbs, as measured by ELISA using multiple flaviviruses or alphaviruses.

Citing Articles

A humanized IgG but not IgM antibody is effective in prophylaxis and therapy of yellow fever infection in an AG129/17D-204 peripheral challenge mouse model.

Thibodeaux B, Garbino N, Liss N, Piper J, Schlesinger J, Blair C Antiviral Res. 2012; 94(1):1-8.

PMID: 22366350 PMC: 3331901. DOI: 10.1016/j.antiviral.2012.02.001.


Development of a human-murine chimeric immunoglobulin M for use in the serological detection of human alphavirus antibodies.

Thibodeaux B, Liss N, Panella A, Roehrig J Clin Vaccine Immunol. 2011; 18(12):2181-2.

PMID: 21976225 PMC: 3232697. DOI: 10.1128/CVI.05269-11.

References
1.
HUNT A, Cropp C, Chang G . A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen. J Virol Methods. 2001; 97(1-2):133-49. DOI: 10.1016/s0166-0934(01)00346-9. View

2.
Kalantarov G, Rudchenko S, Lobel L, Trakht I . Development of a fusion partner cell line for efficient production of human monoclonal antibodies from peripheral blood lymphocytes. Hum Antibodies. 2002; 11(3):85-96. View

3.
Johnson G, Wu T . Kabat database and its applications: 30 years after the first variability plot. Nucleic Acids Res. 1999; 28(1):214-8. PMC: 102431. DOI: 10.1093/nar/28.1.214. View

4.
Roehrig J, HUNT A, Chang G, Sheik B, Bolin R, Tsai T . Identification of monoclonal antibodies capable of differentiating antigenic varieties of eastern equine encephalitis viruses. Am J Trop Med Hyg. 1990; 42(4):394-8. DOI: 10.4269/ajtmh.1990.42.394. View

5.
Thibodeaux B, Roehrig J . Development of a human-murine chimeric immunoglobulin M antibody for use in the serological detection of human flavivirus antibodies. Clin Vaccine Immunol. 2009; 16(5):679-85. PMC: 2681591. DOI: 10.1128/CVI.00354-08. View